University of Virginia — Biomedical Watch V2

Traitements8programmes

Essais5liés

Publications0liées

SourceDBlocale

Traitements

8

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
Bridging the Treatment Gap by Expanding Access to Care for People With Epilepsy in Kenya (BEACON)This cluster randomized trial aims to learn about the effectiveness of task-sharing supported by an epilepsy medical records system (EMRS) (hereafter referred to as BEACON) with patient-tracking data in improving treatment adherence and retention in care in people with epilepsy in western Kenya.	Épilepsie	Non applicable	À vérifier	Kenya	À vérifier
Dapagliflozin 10mg TabThis study aims to investigate the effect of early administration of DAPA during ischemia and before pPCI on infarct size, reperfusion injury-related myocardial damage, cardioprotection from HF, and renoprotection from AKI in patients with AMI.	Maladie coronarienne	Phase 1	À vérifier	United States	À vérifier
Echopulse or Echopulse HDThis study is for adult patients with advanced melanoma who are receiving immunotherapy and who are planning on having surgery for their cancer. All participants in this study will receive an experimental treatment made up of focused ultrasound ablation (FUSA), a non-invasive experimental treatment that uses ultrasound waves to heat and destroy tumor tissue, and an injection in the tumor with an experimental drug that activates the immune system called polyICLC (polyinosinic-polycytidylic acid that is stabilized with carboxymethylcellulose and polylysine). Neither the drug nor the device that are used in this study have been approved by the U.S. Food and Drug Administration (FDA).	Cancer	Phase 1		United States	À vérifier
PolyICLCThis study is for adult patients with advanced melanoma who are receiving immunotherapy and who are planning on having surgery for their cancer. All participants in this study will receive an experimental treatment made up of focused ultrasound ablation (FUSA), a non-invasive experimental treatment that uses ultrasound waves to heat and destroy tumor tissue, and an injection in the tumor with an experimental drug that activates the immune system called polyICLC (polyinosinic-polycytidylic acid that is stabilized with carboxymethylcellulose and polylysine). Neither the drug nor the device that are used in this study have been approved by the U.S. Food and Drug Administration (FDA).	Cancer	Phase 1		United States	À vérifier
Bridging the Treatment Gap by Expanding Access to Care for People With Epilepsy in Kenya (BEACON)This cluster randomized trial aims to learn about the effectiveness of task-sharing supported by an epilepsy medical records system (EMRS) (hereafter referred to as BEACON) with patient-tracking data in improving treatment adherence and retention in care in people with epilepsy in western Kenya.	Épilepsie	Non applicable	À vérifier	Kenya	À vérifier
Echopulse or Echopulse HDThis study is for adult patients with advanced melanoma who are receiving immunotherapy and who are planning on having surgery for their cancer. All participants in this study will receive an experimental treatment made up of focused ultrasound ablation (FUSA), a non-invasive experimental treatment that uses ultrasound waves to heat and destroy tumor tissue, and an injection in the tumor with an experimental drug that activates the immune system called polyICLC (polyinosinic-polycytidylic acid that is stabilized with carboxymethylcellulose and polylysine). Neither the drug nor the device that are used in this study have been approved by the U.S. Food and Drug Administration (FDA).	Cancer	Phase 1		United States	À vérifier
Dapagliflozin 10mg TabThis study aims to investigate the effect of early administration of DAPA during ischemia and before pPCI on infarct size, reperfusion injury-related myocardial damage, cardioprotection from HF, and renoprotection from AKI in patients with AMI.	Maladie coronarienne	Non applicable	À vérifier	Egypt	À vérifier
Dapagliflozin 10mg TabThis study aims to investigate the effect of early administration of DAPA during ischemia and before pPCI on infarct size, reperfusion injury-related myocardial damage, cardioprotection from HF, and renoprotection from AKI in patients with AMI.	Maladie coronarienne	Phase 1	Traitement symptomatique	United States	À vérifier

Essais cliniques

5

Molécule	Indication / population	Phase	NCT	Titre	Statut
Dapagliflozin 10mg Tab	Maladie coronarienne	Phase 1	NCT05762952	SMILE — Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease	COMPLETED
Dapagliflozin 10mg Tab	Maladie coronarienne	Non applicable	NCT06009874	Clinical Investigation of the Cardioprotective Effect of Early Administration of SGLT2 in Patients Presented With AMI	RECRUITING
Echopulse or Echopulse HD	Cancer	Phase 1	NCT06472661	Mel 70 — FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma	RECRUITING
Aminophylline	SEP	Phase 1	NCT01240824	Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer	COMPLETED
Bridging the Treatment Gap by Expanding Access to Care for People With Epilepsy in Kenya (BEACON)	Épilepsie	Non applicable	NCT06623994	Bridging the Treatment Gap by Expanding Access to Care for People With Epilepsy in Kenya (BEACON)	RECRUITING

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.